IQ Capital Partners LLP

IQ Capital Partners LLP is a venture capital firm specializing in seed, series A, early, mid, and late venture growth investments. It also invests in start-ups after post-concept stage and seeks to invest in mature businesses in traditional sectors. The fund also seeks to invest in non-tech companies whose businesses must be post revenue stage. It invests in both pre- and post-revenue stage. It seeks to invest in companies having technology at a post-prototype stage, although investment into disruptive post proof-of-concept technologies is also considered. The fund also seeks to invest in technology based small manufacturing enterprises. The firm invests in all sectors and primarily invests in small and medium enterprises in B2B with a focus on SaaS and PaaS, deeptech, IoT, digital media, enterprise software, med-tech and technology, machine learning and artificial intelligence, advanced engineering and materials, information and communication technologies, life sciences, clean tech, data analytics, data Science and data-based propositions and IP based on disruptive algorithms, cyber security, AdTech, FinTech and e-health, as well as embedded systems and robotics sectors. It seeks to invest in companies based in the United Kingdom and England. It seeks to invest in companies based in or is relocating to an Objective 2 area in less developed parts of the East of England. The firm prefers to invest in Breckland, Luton, North Norfolk Coast, Southend, Waveney, Great Yarmouth, Central Rural Norfolk, Fenland, and Rural East Suffolk. It typically invests across the United Kingdom specifically Cambridge, Oxford, and Bristol areas. The firm invests between £0.3 million ($0.39 million) and £5 million ($7.83 million) with capacity to invest up to £30 million ($32.36 million) per company over its life and later on follows its investments with up to £0.4 million ($0.64 million) with enterprise values between $0.5 million and $10 million. It does not invest as a lead investor but only co-invests with angel investors who are members of Great Eastern Investment Forum. The firm also seeks to invest in companies seeking equity or quasi-equity investments and prefers to make investments by means of equity, preference shares, unsecured loan stock, convertible, and secured loans. It seeks to appoint a board member at its portfolio company. IQ Capital Partners LLP was founded in 2003 and is based in Cambridge, United Kingdom with an additional office in London, United Kingdom.

Jordan Billiald

Associate

Kushaal Desai

Associate

Archie Judd

Associate

62 past transactions

IONATE

Seed Round in 2022
IONATE is creating the hardware-software system for smart grids. Its Hybrid Intelligent Transformer (HIT) replaces traditional transformers with a smart version, integrating data and control of voltages, harmonics, and reactive power into one unit. The HIT helps stabilize power distribution across grids, power generation, industrial facilities, and data centers, while also supporting real-time control nodes.

ToffeeX

Series A in 2022
ToffeeX develops a multi-physics generative AI platform that provides efficient and reliable design alternatives for industrial applications. Its cloud-based software generates complex and efficient shapes that optimize components' performance in a completely automated procedure as well as specializes in fluid-structure generative design results.

Nyobolt

Series B in 2022
Nyobolt is a developer of high-power battery technology used to serve automotive applications. It researches and develops battery technology that could have a higher power, recharge at a faster speed and store large amounts of energy that helps the automotive industry with solutions for high-power applications. The company was founded in 2020 and is based in Cambridge, United Kingdom.

Speechmatics

Series B in 2022
Speechmatics exists to understand every voice. Offering its speech-to-text API engine for solution and service providers to integrate into their stack irrespective of their industry or use case. Businesses use Speechmatics around the world to accurately understand and transcribe human-level speech into text regardless of demographic, age, gender, accent, dialect or location

Boltzbit

Seed Round in 2022
Boltzbit allows data scientists to dramatically speed up the prototyping of various neural network frameworks.

AiM Medical Robotics

Seed Round in 2022
AiM Medical Robotics developing a robotic system for use in neurosurgical procedures. The system is unique in that it is MRI compatible, allowing patients to be treated while in the MRI scanner. This gives physicians the ability to capture real-time imaging feedback to improve outcomes. Its system will help treat patients with Parkinson's, Epilepsy, Tremors, and brain cancer.

OxDX

Pre Seed Round in 2022
OxDX is a spinout that combines the power of single-molecule fluorescent microscopy with machine learning to identify pathogens in under a minute. They use a universal labelling system to light up everything in our sample, image the sample using super-resolution fluorescence microscopy, and analyse the images in our neural network.

Cauldron

Pre Seed Round in 2022
Cauldron aim is to create a Worldbuilding is the art form that is foundational to everything at Cauldron. We want people to truly feel they can not only escape into our worlds, but through the advances of Web3, be a part of them.

causaLens

Series A in 2022
causaLens is pioneering the world’s first platform for building AI data scientists - empowering everyone to create and deploy their own data science agents in days. As data grows exponentially while data science talent remains scarce, organizations struggle to harness their data effectively. Our platform solves this by enabling organizations to create AI Data Scientists tailored to their specific business context and needs. Teams can collaborate in a multi-agent environment, ensuring human oversight across the entire workflow and making AI-powered data science trustworthy and accessible to everyone – from analysts to business leaders. Seamlessly create and share customized data science agents within a secure environment that protects sensitive information, enabling true enterprise-wide collaboration. AI Data Scientists can be created and trained in days, accelerating and expanding business insight and action at an unprecedented scale. We power industry leaders, including Cisco, Johnson & Johnson, Canon, and McCann Worldgroup, to accelerate and scale their data science capability. Imagine if everyone in your organization — from Marketing to Product, Supply Chain to Operations —could have a dedicated data science team. Now, you don’t need to imagine – you can build your own team of AI Data Scientists in just days.

Thought Machine

Series C in 2021
Thought Machine is a Fintech company that builds cloud-native technology to revolutionize core banking. Its mission is to cure one of the banking industry's primary problems: its reliance on outdated IT infrastructure. Nearly every bank is stuck on a legacy IT platform, which cripples their ability to innovate and give their customers the type of service they deserve. The company provides a solution to this is Vault: a complete retail banking platform that is capable of being configured easily to suit the needs of any bank. They have built Vault from the ground up as a cloud-native, microservice API architecture platform. Thought Machine has a deep culture of engineering excellence, and they believe it is this which delivers a solution compelling enough to engender a seismic shift in the banking industry.

Closed Loop Medicine

Series A in 2021
Closed Loop Medicine is the global leader in the development of single prescription drug plus digital therapy (DTx) combination products developed to optimise dosing on an individual level with linked behaviour therapy to improve patient outcomes. The company was founded by an experienced team of healthcare professionals, entrepreneurs and life scientists with experience of both drug and software development, as well as extensive health system innovation experience. The company has two products in development for hypertension and insomnia. It has further products in its pipeline for a wide portfolio of chronic diseases. The Company ensures that both patient and clinician are at the centre of its products design and development.

Valarian Technologies

Seed Round in 2021
Valarian delivers advanced data sovereignty infrastructure engineered to safeguard sensitive data for commercial enterprises and government institutions. Our solution is built to empower customers with full data sovereignty, leveraging strategic localisation, granular access controls, and thorough auditability. Amid rising geopolitical and cyber threats, Valarian fortifies critical operations, enhancing resilience, securing privileged communications, and protecting IP and trade secrets. In this way, we empower corporate and government entities to innovate and compete globally with unwavering confidence. To learn more, visit valarian.com.

NanoSyrinx

Seed Round in 2021
NanoSyrinx is an emerging biotechnology company developing a novel system for targeted delivery of therapeutic proteins and peptides direct to the cytosol. We are using synthetic biology approaches to develop a completely novel method for targeted drug delivery of therapeutic proteins and peptides, to the interiors of cells, to improve efficacy, safety, and economy.

Porotech

Venture Round in 2021
Porotech is a spin-out from the University of Cambridge. It mainly focuses on the development of wide-bandgap compound GaN semiconductors by applying material technologies and solutions to unleash the full potential of GaN to revolutionize the electronics industry. The company was co-founded by Dr. Tongtong Zhu, Dr. Yingjun Liu, and Prof. Rachel Oliver.

Cambridge GaN Devices

Series A in 2021
Cambridge GaN Devices focuses on the development of gallium nitride power devices that enhance energy efficiency in electronic applications. The company offers a range of GaN-based semiconductor products designed to improve power conversion and reduce energy loss in various systems. These devices are utilized in sectors such as renewable energy, electric vehicles, and consumer electronics, contributing to the advancement of greener technologies. Cambridge GaN Devices collaborates with industry partners to drive innovation and facilitate the adoption of its technology in the power semiconductor market.

Pangaea Data

Venture Round in 2021
Pangaea Data provides a machine learning-based software solution making scientific and clinical data more meaningful.

CybSafe

Series A in 2021
CybSafe is cyber security software that educates, nudges, and provides real-time, tailored cyber assistance to users via a mobile and web app. The platform for behavioral security and data analytics assists people in making better security decisions and improving their security behavior. It also provides metrics for security behavior, culture, and risk reporting, allowing organizations to anticipate security issues. CybSafe is built on a data-driven model of human behavior and makes use of SebDB, the world's most comprehensive security behavior database.

Opteran

Seed Round in 2020
Opteran reverse-engineers biological brains to create neuromorphic software for machines. Harnessing 600 million years of evolution, Opteran provides robust, low-cost autonomy on the edge. Without the need for AI, data centers, or training, the Opteran Mind provides general-purpose autonomy in the most challenging and dynamic conditions.

Senseye

Venture Round in 2020
Senseye is the leading cloud-based software for Predictive Maintenance. It helps manufacturers avoid downtime and save money by automatically forecasting machine failure without the need for expert manual analysis. Its intelligent machine-learning algorithms allow it to be used on any machine from any manufacturer, taking information from existing Industrial IoT sensors and platforms to automatically diagnose failures and provide the remaining useful life of machinery.

Nu Quantum

Seed Round in 2020
Nu Quantum is building the quantum networking infrastructure essential to scaling quantum computers, by interconnecting quantum computing cores into large distributed clusters. We are creating full hardware solutions to create entangled qubit networks, including a unique high-speed computer network interface, photonic switching fabric, and control systems to accelerate the roadmap towards multi-core quantum supercomputers and quantum data centres. Partnering with leading QC companies, governments and research groups, we seek to bring this technology to market.

AccelerComm

Series A in 2020
AccelerComm is an exciting semiconductor IP-core company that provides solutions to accelerate the next generations of wireless communications (3GPP rel 14, rel 15 and beyond). Their technology solves the bottleneck that would otherwise limit the speed of next generation wireless communication, namely the error correction decoding that is required to overcome the effects of noise, interference and poor signal strength.

CyberSmart

Series A in 2020
CyberSmart is an automated compliance platform that helps you identify, fix, certify, and protect against security incidents that affect your business. They provide a cybersecurity platform that enables small-to medium-sized businesses (SMBs) to combat the constant threat of cyber-attacks and increasing regulation in an ever-evolving technological landscape and increasingly connected digital operating space.

Privitar

Series C in 2020
Privitar is an enterprise software company with a global client-base across North America, Europe, and Asia. The company is the development and adoption of privacy engineering technology enabling its customers to innovate and leverage data with an uncompromising approach to data privacy. Its software is designed to allow clients to analyze potentially sensitive data while respecting customers’ privacy and confidentiality, resulting in the ability to leverage large, sensitive data sets while ensuring compliance with regulations (such as GDPR, CPRA and HIPAA) and ethical data principles.Privitar was founded in 2014 and is based in London, UK.

Porotech

Seed Round in 2020
Porotech is a spin-out from the University of Cambridge. It mainly focuses on the development of wide-bandgap compound GaN semiconductors by applying material technologies and solutions to unleash the full potential of GaN to revolutionize the electronics industry. The company was co-founded by Dr. Tongtong Zhu, Dr. Yingjun Liu, and Prof. Rachel Oliver.

Concirrus

Series B in 2020
Concirrus is a leading Insurtech specialising in transforming the future of risk selection, pricing and claims using the latest developments in data analytics, AI, machine learning, and digitalisation. Concirrus' intelligence platform Quest, helps organisations improve loss ratios, reduce operational expense and access increased deal sizes, and new trading relationships. By capturing and understanding customer behaviour, delivering data-rich insights at scale, underwriting teams are empowered to make rapid data-driven decisions. Over 20 market-leading companies including Marsh, Beazley, Hiscox, Chaucer and Willis Re trust Concirrus’ technology to power their risk making decisions. Headquartered in London with international presence, Concirrus has a 100-strong team of experts that specialise in data analytics, AI and machine learning, as well as having a rich understanding of the global insurance market.

IOTICS

Series A in 2019
Iotic Labs Ltd. develops an Internet of Things platform for things that allows them to share, create, understand, and exchange data. It provides access to Iotic Space, an environment where things can share data, data can be mashed with different sorts of data from others things, and anything can be related to anything else. The company’s platform enables sensors, electrical things, machines, micro-controllers, data systems, and others to interact with other things. Iotic Labs Ltd. was founded in 2014 and is based in Cambridge, United Kingdom.

MQube

Seed Round in 2019
MQube is transforming one of the biggest financial markets in the UK: the mortgage market. Using innovative technology, data science and a relentless focus on user-experience, MQube are on a mission to solve the challenges faced by mortgage lenders, brokers, landlords and, of course, home buyers. Launching MPowered Mortgages and the MPowered platform live into the market in 2021, MQube have applied artificial intelligence, unique document extraction technology and smart data management to automate lending decisions, giving borrowers certainty and control. With significant financial backing from some of Europe’s leading venture funds, we are a team with a passion for innovation and creative problem-solving.

TurinTech AI

Seed Round in 2019
Unlock the full potential of your code and data with GenAI. TurinTech AI is the leader in automated code optimisation for machine learning and data-heavy applications. We utilise our proprietary optimisation algorithms and LLMs to speed up the time-to-production for your ML projects and applications, cutting computational costs and minimising carbon emissions. Learn more at https://turintech.ai/

Speechmatics

Series A in 2019
Speechmatics exists to understand every voice. Offering its speech-to-text API engine for solution and service providers to integrate into their stack irrespective of their industry or use case. Businesses use Speechmatics around the world to accurately understand and transcribe human-level speech into text regardless of demographic, age, gender, accent, dialect or location

KisanHub

Series A in 2019
KisanHub Agri-Food Supply Chain Software helps Producer Groups to transform their supply chain and improve margins with greater visibility and data driven insights. With all your supply and procurement data together in one convenient dashboard, you can better predict supply and make the most of demand. Choose from a suite of software modules that work seamlessly to provide fast access to crop progress, weather information, satellite imagery, stock levels and delivery schedules.

Closed Loop Medicine

Grant in 2019
Closed Loop Medicine is the global leader in the development of single prescription drug plus digital therapy (DTx) combination products developed to optimise dosing on an individual level with linked behaviour therapy to improve patient outcomes. The company was founded by an experienced team of healthcare professionals, entrepreneurs and life scientists with experience of both drug and software development, as well as extensive health system innovation experience. The company has two products in development for hypertension and insomnia. It has further products in its pipeline for a wide portfolio of chronic diseases. The Company ensures that both patient and clinician are at the centre of its products design and development.

Paragraf

Series A in 2019
Paragraf produces graphene electronic devices using contamination-free technology to deliver commercial-quality products. The company aims to significantly transform the electronics industry by developing high-purity graphene products that enhance technological performance. Paragraf is committed to driving material advancements in electronics through its innovative approach.

Audio Analytic

Series B in 2019
At Audio Analytic, we create exceptional human experiences through a greater sense of hearing. We do this by partnering with leading consumer tech companies to bring intelligence and context to their products through an accurate, robust and compact sense of hearing. This ‘greater sense of hearing’ will help us remember the past, help, improve and extend our hearing in the present and anticipate what we need in the very near future. Our embedded software platforms (ai3™ and ai3-nano™) have been licensed to some of the world’s most prominent companies and are suitable for a wide range of products from smart speakers and video doorbells to smartphones, xR glasses and true wireless earbuds.

Closed Loop Medicine

Seed Round in 2019
Closed Loop Medicine is the global leader in the development of single prescription drug plus digital therapy (DTx) combination products developed to optimise dosing on an individual level with linked behaviour therapy to improve patient outcomes. The company was founded by an experienced team of healthcare professionals, entrepreneurs and life scientists with experience of both drug and software development, as well as extensive health system innovation experience. The company has two products in development for hypertension and insomnia. It has further products in its pipeline for a wide portfolio of chronic diseases. The Company ensures that both patient and clinician are at the centre of its products design and development.

causaLens

Series A in 2019
causaLens is pioneering the world’s first platform for building AI data scientists - empowering everyone to create and deploy their own data science agents in days. As data grows exponentially while data science talent remains scarce, organizations struggle to harness their data effectively. Our platform solves this by enabling organizations to create AI Data Scientists tailored to their specific business context and needs. Teams can collaborate in a multi-agent environment, ensuring human oversight across the entire workflow and making AI-powered data science trustworthy and accessible to everyone – from analysts to business leaders. Seamlessly create and share customized data science agents within a secure environment that protects sensitive information, enabling true enterprise-wide collaboration. AI Data Scientists can be created and trained in days, accelerating and expanding business insight and action at an unprecedented scale. We power industry leaders, including Cisco, Johnson & Johnson, Canon, and McCann Worldgroup, to accelerate and scale their data science capability. Imagine if everyone in your organization — from Marketing to Product, Supply Chain to Operations —could have a dedicated data science team. Now, you don’t need to imagine – you can build your own team of AI Data Scientists in just days.

Neurovalens

Series A in 2019
Neurovalens delivers innovative solutions in the field of neuroscience, bioscience and neurophysiology.Neurovalens has received support from Invest NI under the European Union’s Investment for Growth and Jobs Programme. The project, recorded on the ERDF beneficiaries’ website, will be implemented over the next one year, undertaking research and development activities aimed at improving the competitiveness of the business.

Concirrus

Venture Round in 2018
Concirrus is a leading Insurtech specialising in transforming the future of risk selection, pricing and claims using the latest developments in data analytics, AI, machine learning, and digitalisation. Concirrus' intelligence platform Quest, helps organisations improve loss ratios, reduce operational expense and access increased deal sizes, and new trading relationships. By capturing and understanding customer behaviour, delivering data-rich insights at scale, underwriting teams are empowered to make rapid data-driven decisions. Over 20 market-leading companies including Marsh, Beazley, Hiscox, Chaucer and Willis Re trust Concirrus’ technology to power their risk making decisions. Headquartered in London with international presence, Concirrus has a 100-strong team of experts that specialise in data analytics, AI and machine learning, as well as having a rich understanding of the global insurance market.

Apperio

Series A in 2018
Apperio’s legal spend management software provides real-time visibility to help control and optimize external spending with law firms. Data is gathered automatically, structured consistently, and presented simply for analysis to help clients make informed business decisions. Their unique approach of connecting directly with law firms’ practice management systems provides ongoing and historical data at the touch of a button. This gives you complete cost certainty on both billed matters and work-in-progress legal fees. Apperio helps in-house teams to stay in control of their legal spending and build trust with external counsel by offering a collaborative, rather than an adversarial approach to legal spend management.

Spectral Edge

Series A in 2018
Spectral Edge combines patented Image Fusion tech with Deep Learning to reveal more of the color, detail and clarity in any image.

Myrtle Software

Venture Round in 2017
Myrtle.ai is an AI technology company. We optimize machine learning inference workloads for multiple applications in cloud or enterprise data centers and in edge applications. Our products, expertise and IP ensure all available compute resources are optimized for cost, throughput, latency and energy.

BMLL Technologies

Venture Round in 2017
BMLL Technologies is the leading, independent provider of Level 3 Historical Data and Analytics for the world’s most sophisticated Capital Markets participants. Level 3 data captures and displays the trading intentions of all market participants. BMLL clients access this deep data to derive predictable insight. Researchers and quants across global financial services are empowered to truly understand how markets behave and predict the future price movements of securities. BMLL provides banks, brokers, asset managers, hedge funds, global exchange groups and academic institutions with immediate and flexible access to Level 3, harmonised, T+1 order book data and advanced pre and post-trade analytics, in a scalable compute environment. Founded in 2014 in the machine learning laboratories, University of Cambridge, the BMLL Data Science as a Service platform enables users to gain the insight they need for order book simulation, back-testing, trading and data efficiency, risk and compliance measurement, market impact profiling, benchmarking and data sales - without the need to buy, curate or harmonise data. BMLL delivers cost-effective access to its cloud-native Data Science environment via a single web portal, with unlimited compute power and a long history of the most granular, full order book data across global equities, futures and ETFs. BMLL clients accelerate research, optimise trading strategies and generate alpha at unparalleled speed and scale.

Privitar

Series A in 2017
Privitar is an enterprise software company with a global client-base across North America, Europe, and Asia. The company is the development and adoption of privacy engineering technology enabling its customers to innovate and leverage data with an uncompromising approach to data privacy. Its software is designed to allow clients to analyze potentially sensitive data while respecting customers’ privacy and confidentiality, resulting in the ability to leverage large, sensitive data sets while ensuring compliance with regulations (such as GDPR, CPRA and HIPAA) and ethical data principles.Privitar was founded in 2014 and is based in London, UK.

Audio Analytic

Series A in 2017
At Audio Analytic, we create exceptional human experiences through a greater sense of hearing. We do this by partnering with leading consumer tech companies to bring intelligence and context to their products through an accurate, robust and compact sense of hearing. This ‘greater sense of hearing’ will help us remember the past, help, improve and extend our hearing in the present and anticipate what we need in the very near future. Our embedded software platforms (ai3™ and ai3-nano™) have been licensed to some of the world’s most prominent companies and are suitable for a wide range of products from smart speakers and video doorbells to smartphones, xR glasses and true wireless earbuds.

Funderbeam

Venture Round in 2016
Funderbeam is a funding and trading platform that connects companies and investors to buy and sell equity stakes. The platform allows the founders to gain exposure, legal support, a funding manager, or an investor network. It also allows the investors to take control of their investments and trade anytime they want. The company was founded in 2013 as a global data platform for startup companies.

Senseye

Seed Round in 2016
Senseye is the leading cloud-based software for Predictive Maintenance. It helps manufacturers avoid downtime and save money by automatically forecasting machine failure without the need for expert manual analysis. Its intelligent machine-learning algorithms allow it to be used on any machine from any manufacturer, taking information from existing Industrial IoT sensors and platforms to automatically diagnose failures and provide the remaining useful life of machinery.

Fluidic Analytics

Series B in 2016
Fluidic Analytics was formed in 2013 as a spin-out from the Department of Chemistry at the University of Cambridge. Their roots stretch back to a group of scientists who were inspired by the roles that proteins play in the biological world, driven to understand more about how proteins behave and function, but frustrated by the lack of suitable tools for protein characterisation. So they decided to invent their own. Their vision is that protein science will transform their understanding of how the biological world operates in real time. They believe that this transformation will be every bit as revolutionary as the way that advances in DNA sequencing have transformed their understanding of how the biological world operates over decades, lifetimes and generations. And they believe that Fluidic Analytics can help make this vision a reality by developing products that enable easier, faster, more convenient and more accurate protein characterisation, whether in the lab, at the bedside or in everyday life. They've combined cutting edge technology, a fantastic team and best practice in management and communication to go from their founding to a customer ready prototype in 2 years. And they’re only just beginning. This instrument is just the first step towards a platform technology that will serve as the interface between the biological and digital world – as they continue to expand what is possible for their customers. Their desire for accessibility and openness is present in their company’s culture of communication and integrity, in the usability of their products, in their open exchange of ideas with their collaborators and in their commitment to their users complete ownership of their own data. They believe that in working this way, they have the opportunity to create not just a company, but a community that fundamentally improves how they live.

Privitar

Seed Round in 2016
Privitar is an enterprise software company with a global client-base across North America, Europe, and Asia. The company is the development and adoption of privacy engineering technology enabling its customers to innovate and leverage data with an uncompromising approach to data privacy. Its software is designed to allow clients to analyze potentially sensitive data while respecting customers’ privacy and confidentiality, resulting in the ability to leverage large, sensitive data sets while ensuring compliance with regulations (such as GDPR, CPRA and HIPAA) and ethical data principles.Privitar was founded in 2014 and is based in London, UK.

BioBeats

Seed Round in 2016
BioBeats is a human company that creates digital artificial intelligence products to tackle mental health globally. Mental and substance use disorders constitute 10.4% of the global burden of disease and are the leading cause of disability among all disease groups. The global direct and indirect economic costs of mental disorders were estimated at US$2.5 trillion in 2010, and are growing. Both direct and indirect costs of mental disorders are expected to double by 2030. Current clinical and social provisions are inadequate and rely on therapeutic devices that cannot track neurological and physiological correlates to psychological progress. Smartphones and wearables brought real-time data. BioBeats is the result of 15 years of research, 5 of which have been in commercial/clinical/consumer deployment. Their team fuses work at the Institute of Biomedical Engineering and the Social Cognition Lab at the University of Oxford to use real-time data not only to bring physiological data to psychological therapy but to produce machine learning that can predict the onset of the disorder and intervene early. BioBeats was established in 2012 and is based in London, England, United Kingdom.

Desktop Genetics

Venture Round in 2015
Desktop Genetics is an international biotechnology company to helps researchers discover and treat the root genetic causes of human disease. Desktop Genetics is a recognized leader in genome editing technology, staffed by a dedicated team of genome editing experts, bioinformaticians, and data scientists. The company's tools and technologies are used by organizations all over the world. It enables the work of their pharma, biotech, and academic customers working in drug discovery and functional genomics.

Divido

Seed Round in 2015
Divido is a global white label consumer lending platform for financial institutions and multinational retailers. Rapidly build new revenue streams, improve the customer experience and increase conversion by offering finance at the point-of-purchase with Divido. The platform is omnichannel, available online, in-store and via mobile, and works across multiple countries through one integration. Over 1000 partners work with Divido including Nordea Finance, BNP Paribas, BMW, Lenovo and last minute. Divido offers financial services for merchants, lenders, and intermediaries that want to offer instant new credit as a payment option to their end-consumers and corporate clients. Backed by the investors behind Skype, WorldPay, and TransferWise the company launched late 2015 and currently has 300+ partners using its platform including some of the world's well-known brands. By the end of 2017. Divido will operate in 9 countries. Divido was founded in 2014 and is based in London, England, United Kingdom

Unbound

Venture Round in 2015
Unbound is an innovative online crowd-funded publisher that enables authors to present their book ideas directly to readers. Through this platform, readers can pledge their support for projects they find appealing. Once a book garners sufficient backing to ensure financial viability, the author proceeds with writing, while Unbound manages the subsequent processes of editing, typesetting, printing, and distribution. Notably, the names of all the supporters who contributed to the project are included in the published work. This model not only fosters a collaborative relationship between authors and readers but also enhances the publishing landscape by allowing for diverse voices and ideas to emerge.

Atto

Venture Round in 2015
Atto takes the lead with a clear mission, to shape a more predictable future for lenders. Using real-time bank transaction data, Atto delivers a suite of predictive models to empower risk management. Atto offers a range of insights that gives risk managers a detailed view of customer spending, saving, and earning. This added level of understanding enhances credit risk assessment and promotes a more compliant lending environment. Providing accurate foresight lies at the heart of Atto's values. By leveraging current financial information, consumers are more likely to receive equitable treatment, whilst businesses gain the tools to make more informed and appropriate lending decisions. With innovation in data science at its core, Atto paves the way for a future where complex decisions can be made in real-time with impossibly recent data.

Atto

Venture Round in 2014
Atto takes the lead with a clear mission, to shape a more predictable future for lenders. Using real-time bank transaction data, Atto delivers a suite of predictive models to empower risk management. Atto offers a range of insights that gives risk managers a detailed view of customer spending, saving, and earning. This added level of understanding enhances credit risk assessment and promotes a more compliant lending environment. Providing accurate foresight lies at the heart of Atto's values. By leveraging current financial information, consumers are more likely to receive equitable treatment, whilst businesses gain the tools to make more informed and appropriate lending decisions. With innovation in data science at its core, Atto paves the way for a future where complex decisions can be made in real-time with impossibly recent data.

Digital Assess

Series B in 2014
Digital Assess gives you one product made up of a set of dependable tools designed to capture and assess skills from a single location. Our technology lets you make razor-sharp judgements with ease and gives learners the chance to demonstrate every facet of applied knowledge. We work with some of the world’s most trusted education brands to support and improve the whole learning process.

Focal Point Data Risk

Private Equity Round in 2014
Focal Point Data Risk is a new type of risk management firm, one that delivers a unified approach to addressing data risk through a unique combination of service offerings. Focal Point has brought together industry-leading expertise in cyber security, identity governance and access management, data privacy and analytics, internal audit, and hands-on training services, giving companies everything they need to plan and develop effective risk and security programs. By integrating these services, we provide our clients with the flexible support they need to protect and leverage data across any part of their organization. Simply put, Focal Point is the next generation of risk management.

Atto

Venture Round in 2013
Atto takes the lead with a clear mission, to shape a more predictable future for lenders. Using real-time bank transaction data, Atto delivers a suite of predictive models to empower risk management. Atto offers a range of insights that gives risk managers a detailed view of customer spending, saving, and earning. This added level of understanding enhances credit risk assessment and promotes a more compliant lending environment. Providing accurate foresight lies at the heart of Atto's values. By leveraging current financial information, consumers are more likely to receive equitable treatment, whilst businesses gain the tools to make more informed and appropriate lending decisions. With innovation in data science at its core, Atto paves the way for a future where complex decisions can be made in real-time with impossibly recent data.

Atto

Seed Round in 2012
Atto takes the lead with a clear mission, to shape a more predictable future for lenders. Using real-time bank transaction data, Atto delivers a suite of predictive models to empower risk management. Atto offers a range of insights that gives risk managers a detailed view of customer spending, saving, and earning. This added level of understanding enhances credit risk assessment and promotes a more compliant lending environment. Providing accurate foresight lies at the heart of Atto's values. By leveraging current financial information, consumers are more likely to receive equitable treatment, whilst businesses gain the tools to make more informed and appropriate lending decisions. With innovation in data science at its core, Atto paves the way for a future where complex decisions can be made in real-time with impossibly recent data.

Atto

Venture Round in 2012
Atto takes the lead with a clear mission, to shape a more predictable future for lenders. Using real-time bank transaction data, Atto delivers a suite of predictive models to empower risk management. Atto offers a range of insights that gives risk managers a detailed view of customer spending, saving, and earning. This added level of understanding enhances credit risk assessment and promotes a more compliant lending environment. Providing accurate foresight lies at the heart of Atto's values. By leveraging current financial information, consumers are more likely to receive equitable treatment, whilst businesses gain the tools to make more informed and appropriate lending decisions. With innovation in data science at its core, Atto paves the way for a future where complex decisions can be made in real-time with impossibly recent data.

Grapeshot

Venture Round in 2009
Grapeshot (Acquired by Oracle) empowers the world’s leading brands and advertisers to bring relevance to every customer experience. With its proprietary Contextual Intelligence platform, Grapeshot transforms information into actionable data, and identifies revenue-driving behaviors. With solutions for predictive targeting, brand safety, and audience enrichment, advertisers, media agencies, programmatic platforms and publishers use power of Grapeshot to improve media efficiency, increase customer engagement and boost brand perception with their intended audiences. It has been named “Digiday’s Best Publisher Tool” and “Best Attribution Solution for Keyword Signal,” The Drum’s “Best Attribution Solution,” and the British Media Awards’ “Ad Provider of the Year,” among other honors. Grapeshot entered the market in 2006, and has offices in San Francisco, Los Angeles, Chicago, Toronto, New York, London, Cambridge, Singapore, Hong Kong, Shanghai and Sydney.

Phonetic Arts

Venture Round in 2008
Phonetic Arts Limited delivers technology that generates natural expressive speech, allowing computer games to say various sentences in various types of voices. It offers Phonetic Morpher, which transforms speech to sound like it comes from a different character; Phonetic LipSync, which provides the lip sync information for natural and recorded speech; and Phonetic Synthesizer, which transforms the way speech is used in games. The company, formerly known as Tayvin 356 Limited, was founded in 2006 and is based in Cambridge, the United Kingdom.

Spikes Cavell & Co

Venture Round in 2007
The creative appilcation of data, analyis and technoloyg to underpin public sector procurement transformation. Spikes Cavell – a leading light in spend management. Spikes Cavell is a leader in data-based solutions. Their extensive expertise was built up through developing innovative data-based solutions to support decision making and programme execution in the private sector. Since 2004, Spikes Cavell have turned their attention to translating this experience into producing solutions to help public sector organisations transform their procurement. Their years of experience, combined with their track record in delivering on their promises, have helped them become the leading supplier of spend management solutions to the public sector. Spikes Cavell customers include organisations from all areas of the public sector, nationwide and number over 600. Spikes Cavell & Co. was founded in 1991 and is based in Newbury, United Kingdom.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.